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4. INTRODUCTION 
4.1  General anaesthesia
General anaesthesia is a state defined by a reversible drug induced loss of consciousness, 
areflexia and analgesia (1). The discovery of general anaesthesia, in the mid 19th century, 
is considered a major milestone in medical history, making modern surgery possible by 
rendering the patient unaware of, and unresponsive to, painful stimulation. Although GA 
are administered to millions of patients each year (2), the exact mechanisms of 
unconsciousness still remain elusive.  
 Anaesthetics appear to act on the cell membrane by interacting with the main 
components, namely lipids, proteins and oligosaccharides (3). Meyer and Overton 
proposed the lipid theory by showing a close correlation between anaesthetic potency and 
lipid solubility at the beginning of the 20th century (4). However, interaction of 
anaesthetics with functional membrane proteins became evident as the activity of purified 
luciferase (a soluble lipid-free enzyme responsible for the luminescent reaction in firefly) 
was inhibited by GA (5).  
The idea that anaesthetics act by disrupting lipid bilayers or some other nonspecific 
mechanisms is largely abandoned, and anaesthetics at clinical concentrations are now 
thought to exert their effects selectively by binding directly to specific proteins (5).  
  
        Much research have focused on identifying a particular brain region on which 
anaesthetics act to induce their effects (6). The most sensitive regions appear to be the 
thalamic sensory relay nuclei and the deep layer of the cortex to which these nuclei 
project. This constitutes the route taken by sensory impulses reaching the cortex, so 
inhibition can result in a lack of awareness of sensory input. As the anaesthetic 
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concentration is increased, all brain functions are affected, including motor control, reflex 
activity, respiration and autonomic regulation (7).    
 
4.2  Cellular mechanisms of general anaesthesia     
At the cellular level, the effect of anaesthetics is mainly to inhibit excitatory synaptic 
transmission. In 1906 Sherrington reported that chloroform blocked reflex activity in the 
spinal cord at lower concentrations than needed to inhibit impulse propagation along 
nerve fibres (8). Numerous studies have since implicated that inhibition of synaptic 
transmission could be due to reduced transmitter release, increased transmitter uptake, 
inhibition of the action of the transmitter, or reduced excitability of the postsynaptic cell 
(9, 10).   
      GA may effect the impulse conduction on several sites like: 1. Afferent nerve fibres, 
2. Excitatory synapse, 3. Inhibitory synapse, 4. Postsynaptic neurone. Clinically relevant 
doses of isoflurane depress impulse conduction in thin, unmyelinated, afferent nerve 
fibres, whereas almost no effect is found on impulse propagation in thicker, myelinated 
fibres (11). Furthermore, isoflurane hyperpolarizes the postsynaptic neuron (12), making 
the cell more refractory to membrane depolarisation. 
     
4.3 Molecular mechanisms of general anaesthesia 
 GA in supraclinical doses act non-specifically, leading to a variety of effects. In 
clinically relevant doses, however, GA are thought to exert its effects directly on proteins, 
possibly binding to a hydrophobic area of the protein and inhibiting its normal function 
(5). The most likely targets are VGCC, LGIC and second messenger systems.  
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 The molecular target for intravenous anaesthetics, such as propofol, is identified 
as the GABAA receptor, with functional effects possibly depending on the receptor 
subunit composition (7). For VA, such as isoflurane and sevoflurane, there are currently 
three main candidates: 1. GABAA receptors, 2. Two-pore-domain K+ channels, and 3. 
NMDA receptors. In addition, there are evidence for involvement of several minor 
targets, such as inhibitory glycine receptors and cyclic-nucleotide-gated (HCN) channels, 
which underlie the hyperpolarisation-activated cation current, and presynaptic Na+ 
channel subtypes (7).  
 
4.4 The presynaptic terminal and signal transduction 
Depolarization of nerve terminals opens VGCC coupled to the exocytotic machinery and 
facilitates signal transduction by releasing neurotransmitters (13). Neurotransmitter 
release has been intensively studied since 1950, using the frog neuromuscular synapse as 
a model (14). The influx of Ca2+ further propagates Ca2+ release from internal stores, such 
as the ER and the mitochondria. The resulting increase in cytosolic Ca2+ initiates the 
fusion of neurotransmitter containing vesicles with the plasma membrane. The released 
neurotransmitter diffuses across the synaptic cleft and may interact with postsynaptic 
receptors, leading to either excitatory or inhibitory stimuli, depending on the 
neurotransmitter or postsynaptic receptor involved. The signal transduction process is 
terminated by enzymatic breakdown or reuptake into either the presynaptic terminal or 
adjacent glial cells (15). 
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4.5 Transmitter substances 
The predominant excitatory neurotransmitters in the mammalian brain, glutamate and 
acetylcholine, allow the passage of Na+ and Ca2+ and thereby depolarize the plasma 
membrane toward the threshold potential required for triggering an action potential (15).  
The major inhibitory neurotransmitters, GABA and glycine, usually affect Cl- channel 
receptors and render the target cell more difficult to depolarize (16).  
To summarize, the nerve terminal converts an electrical signal to a chemical signal, and 
the postsynaptic cell converts the chemical signal back to an electrical one. Anaesthetics 
may exert their effects by disrupting signal transduction along these pathways. Matthews 
and Quilliam in 1964, provided the first evidence that anaesthetics may reduce the nerve 
impulse induced amount of transmitter release (17). Considerable evidence now indicate 
that VA potentiate the effect of inhibitory postsynaptic receptors, predominantly the 
GABAA-receptor, as well as depress the effect of excitatory postsynaptic receptors (18-
25). Previous studies from our lab has also shown that isoflurane increase uptake velocity 
of glutamate into presynaptic terminals in the high affinity area (26). 
 
4.6  Intracellular Ca2+ and voltage gated Ca2+ channels 
Intracellular Ca2+ is an important second messenger that controls neurosecretion and 
neuronal excitability through at least five major classes of VGCC, which are known as 
the L, N, P/Q, R and T subtypes (27). Furthermore, cytosolic Ca2+-homeostasis is 
regulated by the Ca2+-ATPase and the Na+/Ca2+ exchanger, which in neurons pump Ca2+ 
out of cytosol and intracellular organelles, including ER and mitochondria (13). In the 
ER, Ca2+ is controlled by IP3 and ryanodine receptors, which after stimulation release 
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Ca2+ (Ca2+ dependent Ca2+ release), and by the Ca2+-ATPase that actively pumps Ca2+ 
from the cytoplasm back into the ER (28). 
Studies on the P/Q – and the N-types of the VGCC, which are the most influential in the 
Ca2+-dependent presynaptic release of neurotransmitters have revealed only a modest 
sensitivity to VA (29-31). Furthermore, data indicate no significant effect of VA on basal 
[Ca2+]i (30, 32). However, in studies on hippocampus slices and acutely dissociated 
neurons it has been reported an increased basal [Ca2+]i in response to clinically relevant 
concentrations of isoflurane (33). In rat synaptosomes, isoflurane tended to increase the 
basal [Ca2+]i (34). 
 
4.7.1 Mitochondrial function 
The mitochondria play an essential role in cellular homeostasis. Structurally, they 
comprise of an outer membrane, that is freely permeable to most ions and small 
molecules, and an impermeable inner membrane with specialized carriers and 
transporting systems.  
 The electron transport chain is present in the inner mitochondrial membrane and 
is composed of five distinctive complexes responsible for shuttling electrons and 
ultimately ATP synthesis (27). Complexes I, II, and IV function as proton pumps, in 
series with respect to the electron flux and in parallel with respect to the proton circuit. 
Each complex in the respiratory chain receives or donates electrons to carrier enzymes, 
such as coenzyme Q and cytochrome C, and ultimately molecular oxygen and protons are 
reduced to form water at complex IV. The fall in redox potential during the electron flux 
generates an electrochemical proton gradient by pumping protons across the inner 
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mitochondrial membrane. The protons re-enter the mitochondrial matrix through the ATP 
synthesis at complex V and phosporylate ADP to ATP (Fig.1).  
The electrochemical potential around –150 mV across the inner mitochondrial membrane 
therefore drives the three fundamental functions of mitochondria, namely ATP 
generation, Ca2+ uptake/storage, and generation/detoxification of ROS (27, 35-37). 
Furthermore, changes in mitochondrial Ca2+ regulate the enzymes in the tricarboxylic 
acid cycle. 
 
 
Figur 1. Electron transport chain shown coupled to the transport of protons. Reprinted with approval of 
 Lippincott Williams and Wilkins, WK Health, Philadelphia, USA. 
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4.7.2 Mitochondrial Ca2+ uptake and release 
Mitochondrial uptake of Ca2+ during physiological Ca2+ signalling regulates 
mitochondrial metabolism, mainly by up regulating the dehydrogenases of the 
tricarboxylic acid cycle (pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase and 
NAD+ isocitrate dehydrogenase) (37, 38). The influx of Ca2+ into the matrix is dependent 
on the electrochemical gradient for Ca2+, and low resting intramitochondrial Ca2+ 
concentration (39). The main route of entry to the matrix is the uniporter located in the 
inner membrane (40). 
 The Ca2+ extrusion from the mitochondrial matrix is an active process requiring either 
ATP hydrolysis or an extramitochondrial ion travelling down an electrochemical gradient 
(41, 42). In some tissues, Ca2+ is extruded from the mitochondria in exchange for Na+. A 
Na+/H+ antiporter restores the mitochondrial Na+ balance. Excessive mitochondrial Ca2+ 
accumulation in combination with oxidative stress, ATP depletion and high inorganic 
phosphate, may initiate opening of the MPT, resulting in dissipation of the m and 
ceasing of oxidative phosphorylation.  The following ATP depletion may lead to both 
necrotic and apoptotic cell death (43). 
Thus, the respiratory chain generates the m and that in combination with a 
mitochondrial/cytosolic Ca2+ gradient, provides the necessary driving force for 
mitochondrial Ca2+ uptake and release (37).  There has also been suggested Na+ 
independent Ca2+ efflux by either reversal of the uniporter (44) . 
 
4.7.3 Mitochondria and ROS production 
The mitochondria are the major intracellular source of ROS. Complex IV reduces 
molecular oxygen to water. However, about 5 % of this reaction may occur as a single 
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electron reduction at complex III, generating superoxide anion O2-. There is also evidence 
of a minor ROS production at complex I (45). The mitochondria are also vulnerable to 
ROS that may cause DNA strand breakage, peroxidation of polyunsaturated fatty acid 
chains and inhibition of the electron transport chain (45). Furthermore, ROS may increase 
Ca2+ release from intracellular stores, and thereby increase the mitochondrial uptake. 
Current evidence indicates that Ca2+overload and ROS in combination may initiate MTP, 
although the interaction between them is not fully understood.    
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5. THE AIMS OF THE STUDY 
 
The present study was conducted to investigate the effects of isoflurane and sevoflurane, 
the most commonly used VA in neuroanaesthesia (46, 47), on mitochondria from 
cerebrocortical synaptosomes. Mitochondrial function was studied with special emphasis 
on the complexes in the electron transport chain that are important to maintain the 
mitochondrial membrane potential. The effects of VA were then compared with the 
effects of the intravenous anaesthetic propofol. The specific aims were defined:  
 
1. To assess whether sevoflurane affects mitochondrial function in the central 
 nervous system, and to investigate whether an effect involves the activation of 
 mitoKATP. (Paper I) 
 
2. To compare the effects of isoflurane and sevoflurane on the [Ca2+]i and the 
 m, and to explore  whether clinically relevant concentrations affect the 
 m by inhibition of the electron transport chain. (Paper II) 
 
3. To investigate whether the mitochondrial sensitivity to anaesthetics is related to 
 age and the relationship to intervention of the respiratory chain activity. 
 (Paper III) 
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4. To investigate and compare the effects of sevoflurane and propofol on [Ca2+]i and 
 the m in rat and human cerebrocortical synaptosomes, and relate the changes to 
 interventions in the electron transport chain. (Paper IV) 
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6. MATERIALS AND METHODS 
6.1 The synaptosomal preparation 
Isolated nerve terminals (synaptosomes) have been in use since the beginning of the 
1960s (48) to investigate presynaptic function. Through a process of homogenization and 
centrifugation (49), the nerve terminals are pinched off and resealed (Fig.2). The 
synaptosomes contain mitochondria and are able to maintain the ATP levels for more 
than 6 hours when kept on ice (49, 50). Preserved in a medium with a low K+ 
concentration, they maintain a membrane potensial of -60 mV to -80mV (51) and a 
cytoplasmic free Ca2+ concentration of 0.1-0.2 M (52). The synaptosomal preparation is 
thus regarded energetically intact (13).  There are two main experimental advantages 
using this preparation. First, it is the simplest preparation with an intact plasma 
membrane and cytoplasm including mitochondria, metabolic pathways, and machinery 
for uptake, storage, and release of neurotransmitter. Secondly, it is free from glial and 
neuronal cell body elements (53). The synaptosomal preparation can be made from the 
animal or human brain of any age, in contrast to the neonatal requirement of most 
neuronal cell cultures.  
 There are numerous mitochondria in the nerve terminals (54). Although not 
representative of an intact neuron, the synaptosomal preparation represents a simple 
model for investigating mitochondrial and cellular function (13, 54), and seems ideal 
when studying the effects of neuropharmacological agents on mitochondrial function in 
the brain. There are, however, differences in the function of mitochondria in the neuronal 
soma and mitochondria situated in the presynaptic terminal (55), which underline the 
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importance of studying mitochondrial function both in neurons and in presynaptic 
terminals in isolation. 
 
 
Fig. 2. Electron microscopic picture of the 
synaptosomal preparation from rat brain 
used in these thesis showing isolated 
presynaptic boutons (B). Some 
postsynaptic elements such as a 
postsynaptic spinae (S) connected to the 
presynaptic terminals in dense synaptic 
clefts. Magnification: X 64 000.  With 
approval of Reidun Torp, Centre for 
Molecular Biology and Neuroscience, 
Oslo, Norway.
 
 
 
6.2 Measuring mitochondrial function using fluorescent probes 
In the present work a time-course registration of functional mitochondrial parameters was 
studied using a fluorescence spectrophotometer (Hitachi Ltd., Tokyo, Japan). 
Synaptosomal [Ca2+]i was measured as the fluorescence of fura-2 (Molecular Probes, the 
Netherlands), a ratiometric dye that upon binding to Ca2+ exhibits a shift in the excitation 
maximum (56). Fura-2 is excited at 340 nm and 380 nm of light, and the ratio of the 
emissions at those wavelengths is directly correlated to the amount of [Ca2+]i. An increase 
in the normalized fura-2 ratio thus indicates an increase in [Ca2+]i. 
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  The m, a central parameter of mitochondrial function, was measured as the 
fluorescence of JC-1, a lipophilic and cationic dye that exhibits potential-dependent 
accumulation in the negatively charged mitochondria. At low concentrations (low m), 
JC-1 exists mainly in a monomeric form, emitting green fluorescence, whereas JC-1 in 
high concentrations (high m) forms aggregates emitting red fluorescence. A reduction 
in the normalized JC-1 ratio indicates a depolarization of the mitochondrial membrane 
(57).  
To assess whether the observed effect of VA on the m was disturbed by interference 
between the two fluorescence probes, single-dye experiments with JC-1 and sevoflurane 
2 MAC were performed. Sevoflurane decreased the m in N-ACSF and in Ca2+ 
depleted ACSF to the same degree as in dual-probe experiments. 
 
6.3 Inhibition of the respiratory chain  
In order to investigate the mechanisms of isoflurane and sevoflurane action on the 
electron transport chain, complex I and V were inhibited by adding oligomycin 2 g/ml 
and rotenone 2 M  
 Oligomycin is a natural antibiotic isolated from Streptomyces
diastatochromogenes which inhibits mitochondrial H+-ATP synthase at complex V (58). 
Oligomycin at high concentrations may also inhibit the plasma membrane Na+-K+-
ATPase. 
 Rotenone is a naturally occurring chemical from the roots of several tropical and 
subtropical plant species belonging to the genus Lonchocarpus or Derris with toxic 
properties towards humans and other mammals.  Its toxic effect is due to a general 
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inhibition of cellular respiration. Specifically, rotenone inhibits the phosphoryl group 
transfer at complex I by inhibiting the transfer of electrons from iron-sulfur centers in 
complex I to ubiquinone, and thereby preventing the conversion of NADH into usable 
cellular energy (ATP)(59). 
6.4 Membrane depolarization 
The synaptosomal plasma membrane can be depolarized with K+ producing a clamped 
depolarisation, which does not, however, mimic physiological conditions (60). A more 
physiological membrane depolarisation is evoked by the K+ channel inhibitor 4-AP (13). 
Using 4-AP, repetitive activation of Ca2+ channels are produced, and most of the Ca2+ 
independent efflux of amino acids seen with  K+  evoked depolarization is avoided (61).  
 In the present investigations the mitochondrial uncoupler FCCP 1 M was added 
after anaesthetic exposure in each experiment to attain maximum mitochondrial 
depolarization.  
6.5 Anaesthetic agents 
Sevoflurane is a methyl propyl ether, which was synthesized in 1968. The initial 
development was slow because of some apparent toxic effects and problems of 
biotransformation and stability with soda lime. The drug has been available for general 
clinical use in Japan since 1990 and has been more recently introduced in Western 
Europe. The blood/partion coefficient of sevoflurane is 0.69, which is about half of that 
of isoflurane (1.43) and closer to that of desflurane (0.42), making the rate of 
equilibration between alveolar and inspired concentration faster than for halothane, 
enflurane and isoflurane, but slower than for desflurane. The MAC value of sevoflurane 
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in adults is between 1.7 and 2% in O2 and 0.6% in 60% N2O (62). It is non-flammable 
and non-irritating. 
      Sevoflurane has established itself as an important neuroanaesthetic agent, as both 
cerebral autoregulation and perfusion pressure is better maintained with sevoflurane than 
with isoflurane (63, 64). Sevoflurane has similar effects on the CNS as halothane, 
isoflurane and desflurane. Intracranial pressure increases at high-inspired concentrations, 
but the effect is minimal over the 0.5-1.0 MAC range. Sevoflurane decreases arterial 
pressure, but cardiac output is well preserved over the normal anaesthetic maintenance 
dose. In summary, sevoflurane produces a smooth and fast induction and a rapid recovery 
with minimal effects on respiratory and circulatory parameters using a clinical anaesthetic 
concentrations. 
       Sevoflurane and all other anaesthetic agents, at supra-clinical doses, however, can 
cause death by loss of cardiovascular reflexes and respiratory paralysis. Increased 
epileptiform electroencephalographic activity and seizure-like motor activity are reported 
in association with sevoflurane administration. (65). There is also a theoretical risk of 
renal toxicity due to the inorganic fluoride ion  
 
 Isoflurane is a halogenated ether inhalation-agent that was initially synthesized in 1965. 
It is non-flammable, suitable for vaporization, and has a low biodegradation as only 0.17 
% is metabolized, with rapid elimination and thus small toxicity (66). A low blood/gas 
partition coefficient of 1.4 provides rapid uptake, distribution and elimination (66). MAC 
is 1.3% in middle aged humans and 1.5% in rats (62). Cerebral blood flow is mainly 
unaltered at concentrations of isoflurane below 1 MAC, and cerebral oxygen 
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consumption is decreased under isoflurane anaesthesia (67). Thus, isoflurane has until 
recently been considered the inhalation anaesthetic of choice in neurosurgery (46, 47). 
 
Propofol is a short acting intravenous agent, clinically available since 1977, mainly used 
for induction of anaesthesia and long-term sedation. Propofol is presented in a 1-2 % 
formulation consisting of an oil and water emulsion. The pharmacokinetic profile is 
characterized by a rapid distribution from blood to tissues, and an equally rapid clearance. 
Propofol is mainly and rapidly metabolized in the liver, but some minor metabolites are 
also detected in the urine. The total body clearance of propofol is greater than liver blood 
flow, indicating an extrahepatic metabolism (68). 
 
 
 
 
 
 
 
 
 
 22
7. SUMMARY OF RESULTS 
7.1 Paper I 
Recent studies have demonstrated that VA increase the ischemic tolerance of the heart by 
activating mitochondrial signalling pathways. In particular, stimulation of mitoKATP has 
been documented (8, 9).  In this study we therefore wanted to test whether sevoflurane 
affects mitochondrial function in the brain by altering the m, and to investigate 
whether activation of mitoKATP might be involved. The effects of sevoflurane on the m 
was related to alterations in [Ca2+]i.  
In Ca2+-containing medium, sevoflurane 1 and 2 MAC gradually decreased the 
normalized JC-1 ratio from 0.96 ± 0.04 in control to 0.92 ± 0.03 and 0.89 ± 0.04, 
representing a decrease in the m (n=9, p<0.01). Furthermore, sevoflurane 2 MAC 
increased [Ca2+]i. In Ca2+-depleted medium, sevoflurane 1 and 2 MAC decreased the 
m while [Ca2+]i remained unaltered. Sevoflurane 2 MAC attenuated the 4-AP induced 
decrease in the m. When mitoKATP was blocked, adding the specific antagonist 5-HD 
500 M, the sevoflurane induced decrease in the m was attenuated, but not blocked. 
The depolarizing effect of sevoflurane compared to FCCP was calculated to 12.2 ± 3.1 % 
in Ca2+-containing medium and 17.4 ± 1.7 % in Ca2+-depleted medium (n=5).  
 This study suggests that sevoflurane in clinically relevant concentrations depolarizes the 
mitochondrial membrane in isolated CNS presynaptic terminals, and that this effect is not 
dependent on Ca2+-influx to the cytosol, even though [Ca2+]i in this situation was 
significantly altered. Opening of mitoKATP is only partly responsible for the depolarizing 
effect of sevoflurane, suggesting that additional mechanisms must be involved.  
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7.2 Paper II 
Having observed that clinical concentrations of sevoflurane affects the m in neural 
mitochondria, we wanted to further elucidate the mechanisms. Earlier studies have 
demonstrated that both VA and barbiturates inhibit the mitochondrial respiration by 
interfering with complex I (69-71) and the oxidative phosphorylation at complex V (69, 
72-74), and thereby proposing the mitochondria as one of the targets for anaesthetic 
agents. The m controls the generation of ATP and ROS, and sequestration of [Ca2+]i. 
The main purpose of the present study was to compare the effects of isoflurane and 
sevoflurane on the m, and to explore whether clinical concentrations of these 
anaesthetics affect the m by inhibition of the electron transport chain. 
 Isoflurane 1 and 2 MAC decreased the normalized JC-1 ratio from 0.92 ± 0.03 in control 
to 0.86 ± 0.02 and 0.81 ± 0.01, respectively, reflecting a depolarization of the 
mitochondrial membrane (n=9). Isoflurane 2 MAC increased [Ca2+]i. In Ca2+-depleted 
medium, isoflurane still decreased the m while [Ca2+]i remained unaltered. The effect 
of isoflurane was more pronounced than for sevoflurane. Blocking complex V of the 
respiratory chain enhanced the isoflurane and sevoflurane induced mitochondrial 
depolarization, whereas blocking complex I and V decreased the m to the same extent 
in control, isoflurane and sevoflurane experiments. 
 This study demonstrates that isoflurane and sevoflurane may act as metabolic inhibitors 
by depolarizing presynaptic mitochondria through inhibition of the electron transport 
chain. Isoflurane seems to inhibit mitochondrial function more pronounced than 
sevoflurane. Both agents inhibit the respiratory chain sufficiently to cause ATP synthase 
reversal. 
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7.3 Paper III 
We further wanted to investigate mitochondrial sensitivity to anaesthetics related to age. 
The sensitivity for GA increases with age, but the mechanism for this age related 
sensitivity is still unknown. The main purpose of the present study was thus to investigate 
the effects of isoflurane on [Ca2+]i and the m in isolated presynaptic terminals from 
neonatal, adolescent, and adult rats. The effect was compared and related to intervention 
of the respiratory chain activity.    
In neonatal rats isoflurane had no significant effect on the m. In adolescent and adult 
synaptosomes, however, isoflurane 1 and 2 MAC decreased the m. Isoflurane 2 MAC 
increased [Ca2+]i in neonatal and adolescent rats, but not in adult synaptosomes. In Ca2+-
depleted medium, isoflurane still decreased the m while [Ca2+]i remained unaltered. By 
blocking complex V of the respiratory chain, the isoflurane induced mitochondrial 
depolarization was enhanced in all age groups. Blocking complex I depolarized the 
mitochondria to the same extent as isoflurane 2 MAC, but without any additive effect.  
 This study demonstrates that isoflurane depolarizes the m of neural mitochondria in an 
age dependent manner by inhibition of the respiratory chain. The effect is more 
pronounced in the adolescent and adult than in neonatal rats. The increased mitochondrial 
sensitivity with age seems to be related to the reversed function of the ATP synthase. 
 
7.4 Paper IV 
Volatile and intravenous anaesthetics influence brain physiology differently. The 
mitochondrial membrane potential drives the main functions of mitochondria. 
Sevoflurane depolarizes neural mitochondria.  There is still, however, limited information 
concerning the effects of anaesthetics on neural mitochondria in humans. The effects of 
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sevoflurane and propofol on [Ca2+]i and the m was therefore compared in rat and 
human synaptosomes, and the changes related to interventions in the electron transport 
chain. 
 Sevoflurane and propofol decreased the m in rat synaptosomes in a dose dependent 
manner, and to the same extent by equipotent doses. Inhibition of complex V enhanced 
the depolarizing effect of sevoflurane 2 MAC, but not of propofol 100 M. Neither 
sevoflurane nor propofol affected [Ca2+]i significantly. Sevoflurane and propofol 
decreased the m in human synaptosomes to the same extent as in the rat experiments. 
 The depolarizing effect of propofol on the m was more rapid in onset than that of 
sevoflurane. Whereas sevoflurane inhibits the respiratory chain sufficiently to cause ATP 
synthase reversal, the depolarizing effect of propofol seems to be related to inhibition of 
the respiratory chain from complex I-V.  
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8. DISCUSSION 
 
The effects of isoflurane, sevoflurane and propofol on mitochondrial function was studied 
in cerebrocortical synaptosomes prepared from the female rat and human brain. The role 
of signalling pathways, such as activation of mitoKATP, and whether these anaesthetics 
affect the m by inhibition of the electron transport chain was investigated. The effects 
of VA was related to alterations in [Ca2+]i.The effects of VA were then compared with 
the effects of the intravenous anaesthetic propofol. 
8.1 The effects of volatile anaesthetics on the mitochondrial membrane 
potential   
Isoflurane and sevoflurane in concentrations corresponding to 1 and 2 MAC depolarized 
the m gradually in a dose dependent manner (paper I and II), while only 2 MAC, a 
clinically relevant concentration in induction of anaesthesia, increased [Ca2+]i slowly. 
When extracellular Ca2+ was removed, isoflurane and sevoflurane 1 and 2 MAC still 
decreased the m without altering [Ca2+]i. The findings imply that most of the 
mitochondrial depolarization caused by the VA administration was independent of 
Ca2+influx to the cytosol. In contrast, a much higher concentration of isoflurane (3.1 mM) 
had to be applied to cortical neuronal-glial cultures to produce a depolarization of the 
m, and this was followed by irreversible cell damage (75).  
The depolarizing effect of isoflurane is more pronounced than for sevoflurane. Still, when 
extracellular Ca2+ was removed, isoflurane decreased the m without affecting the 
[Ca2+]i, and the effect on the m was more pronounced than for sevoflurane. The degree 
of mitochondrial depolarization induced by VA thus seems to be related to altered 
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mitochondrial function rather than effects on Ca2+-influx due to plasma membrane 
depolarization (13). 
The K+-channel inhibitor 4-AP or the mitochondrial uncoupler FCCP was added at the 
end of each experiment to simulate pre-synaptic membrane depolarization or to attain 
maximum mitochondrial depolarization, respectively. A rapid and substantial 
mitochondrial depolarization was achieved by FCCP, while membrane depolarization 
with 4-AP decreased the m moderately.  Isoflurane and sevoflurane 2 attenuated the 4-
AP evoked change in [Ca2+]i  and the m. Compared with FCCP the depolarizing effect 
of isoflurane and sevoflurane was less and more protracted (approximately 27 % in Ca2+ 
depleted medium). The anaesthetics did not change the value of maximum mitohondria 
depolarization with FCCP, this emphasizes that the effects of isoflurane and sevoflurane 
is due to a reduction in the m, and not unspecific additive effects on the JC-1 
fluorescence signal. However, since isoflurane and sevoflurane had an intrinsic 
depolarizing effect on mitochondria, further studies using a shorter time of exposure 
could reveal whether VA attenuate 4-AP induced changes in the m.  
           There is considerable evidence that opening of mitoKATP, either directly or by 
activation of PKC, is important in VA induced cardioprotection (76, 77). This effect has 
to some extent been attributed to a decrease in the m and mitochondrial uncoupling 
(76), as activation of mitoKATP allow K+ to enter into the mitochondria (78). In the brain, 
the density of mitoKATP are higher than in both liver and heart tissue, and these channels 
play a central role in the regulation of mitochondrial matrix volume (79). In this study 5-
HD (paper I), a specific mitoKATP-antagonist, tended to attenuate the anaesthetic induced 
decrease in the m in Ca2+-containing medium, but without reaching statistical 
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significance. In Ca2+-depleted medium, the sevoflurane induced decrease in the m was 
significantly attenuated by 5-HD. However, the m was still significantly decreased by 
the anaesthetic in the presence of 5-HD. Thus, even though sevoflurane is known to 
activate mitoKATP, the anaesthetic-induced mitochondrial depolarization found in this 
study is only partly due to activation of mitoKATP. These findings are in accordance with 
reports where opening of the cardiac mitoKATP depolarized the mitochondria only to a 
minor degree (78, 80).  
Sevoflurane and propofol depolarized the neural mitochondria in rat and human 
synaptosomes to the same degree, but with a different pharmacokinetic profile. Whereas 
propofol depolarized the mitochondria rapidly, sevoflurane exerted its effect more 
gradually. The surgical specimens used in this study were collected from superficial 
cortical structures from patients subjected to a temporal lobe resection due to medically 
intractable epilepsy. The tissue is supposedly normal, but is exposed to ischemia during 
preparation that may produce a pool of nonviable synaptosomes with damaged 
mitochondria, and the results of the present study can therefore not be applied directly to 
the healthy human brain. 
 
What mechanisms are responsible for the depolarization of the m in presynaptic 
mitochondria?  
 
 Complex I, III, and IV in the electron transport chain act as proton pumps that generate 
an electrochemical potential of about -150 mV across the inner mitochondrial membrane.  
The energy generated is used to produce ATP and to buffer intracellular Ca2+ whenever 
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the local [Ca2+]i rises above a critical "set point" (27, 37, 81, 82).  The m is therefore 
regarded a central parameter of mitochondrial function (37, 82). Mitochondrial 
depolarization can result from increased ATP demand or increased Ca2+-influx (83). In 
both cases, mitochondrial ATP synthase at complex V would continue to function and 
maintain the cytosolic ATP/ADP ratio. Impaired electron transport or substrate supply, 
and enhanced inner membrane proton permeability would also depolarize the 
mitochondria (83). Furthermore, activation of other ionic channels in the mitochondrial 
membrane, such as mitoKATP, could to some degree reduce the m (84). Additionally, it 
must be kept in mind that synaptic and non-synaptic mitochondria differ somewhat in 
their metabolic properties. Notably, synaptic mitochondria have a lower respiration rate 
and complex IV activity, which may render them more susceptible to insults such as 
ischemia (85). 
 
8.2 The effects of volatile anaesthetics on the electron transport chain 
Mitochondrial depolarization can be caused by respiratory chain inhibition, impaired 
substrate supply, or enhanced inner membrane proton permeability. Under these 
conditions, cytosolic ATP is consumed as complex V operates in a reverse mode to 
extrude matrix protons in an attempt to maintain the m (27).  In cells or subcellular 
fractions with active glycolysis, respiratory chain inhibition at complex I to IV will 
therefore cause only a partial depolarization, because ATP synthase reversal at complex 
V can maintain a suboptimal m (27). In the present thesis, the finding of a 
considerably more depolarized mitochondrial membrane during isoflurane and 
sevoflurane (paper II) experiments when complex V was blocked indicates that the 
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mitochondrial membrane was sufficiently depolarized by the anaesthetics to partly 
reverse the function of ATP synthase at complex V. These findings in presynaptic 
terminals are in coherence with the effect of barbiturates on neural mitochondria in rat 
cortical neural cultures (86).    
In synaptosomes, rotenone inhibition of complex I causes a drop in ATP levels (27), 
rendering the cell function dependent on the glycolytic capacity for ATP supply (87). The 
present study demonstrates that isoflurane depolarizes the m to the same extent as 
rotenone (paper III). Isoflurane did not potentiate the effects of rotenone on the 
mitochondria, suggesting related uncoupling mechanism. FCCP was still able to decrease 
the m, indicating residual mitochondrial function. These findings are in accordance 
with other studies indicating that complex I is the most sensitive complex of the electron 
transport chain to inhibition by VA in mammalian mitochondria as shown in cardiac 
mitochondria (87).  
After blocking complex I and inhibiting the ATP synthase reversal at complex V, neither 
isoflurane nor sevoflurane at concentrations corresponding to 2 MAC did significantly 
decrease the m further. Still, FCCP was able to decrease the m, indicating that there 
was not complete collapse of the m. These data suggest that clinical concentrations of 
isoflurane and sevoflurane depolarize presynaptic mitochondria by inhibition of the 
electron transport chain. VA thus seem to act as weak metabolic inhibitors of 
mitochondrial respiration as suggested by researchers more than 30 years ago (70), and 
this effect induces a mild depolarization of presynaptic mitochondria even at clinical 
concentrations.   
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8.3 The effects of volatile anaesthetics on free cytosolic Ca2+
 Ca2+ regulation in synaptosomes ([Ca2+]i) was investigated by administration of saturated 
solutions of isoflurane and sevoflurane and testing immediate response on [Ca2+]i. In an 
environment with extracellular Ca2+-concentration of 1.3 mM, isoflurane and sevoflurane 
2 MAC increased the basal [Ca2+]i (paper I and II). The findings are in accordance with 
studies using brain slices and dissociated neurons (33), while earlier experiments with 
synaptosomes have failed to demonstrate any significant increase in [Ca2+]i after 
isoflurane exposure (33, 34, 88). In contrast to changes in the m, the anaesthetics had 
the opposite effect on [Ca2+]i, as isoflurane 2 MAC caused a smaller increase in [Ca2+]i 
than sevoflurane 2 MAC (84, 89). This is interesting as increased basal [Ca2+]i-levels 
augments the probability of inducing seizures (34). Epileptiform electroencephalographic 
activity and seizure-like motor activity have in fact been reported during sevoflurane 
anaesthesia (65).  
Previous studies on the VGCC, which are the most influential in the Ca2+-dependent 
presynaptic release of neurotransmitters, have revealed only a modest sensitivity to VA 
(5, 31). However, recent studies have shown that anaesthetics may attenuate the 
depolarization-induced Ca2+-increase in the presynaptic independently of VGCC by 
inhibiting the Ca2+-dependent Ca2+-release from ER (90, 91).   
 
In the present studies isoflurane and sevoflurane also increased basal [Ca2+]i in 
synaptosomes with relatively high extracellular Ca2+-concentration (Paper I & II), that 
increased the Ca2+-load into the presynaptic terminals (Paper I). The anaesthetics could 
thus potentially inhibit Ca2+-uptake into presynaptic Ca2+-stores such as ER (28), as 
described in kidney cells (92), or attenuate mitochondrial Ca2+-buffering (59), as 
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discussed later. However, the effects of isoflurane and sevoflurane on the m was 
independent of Ca2+-influx to the cytosol. The effects of isoflurane and sevoflurane on 
cytosolic Ca2+-homeostasis in the presynaptic terminal are interesting topics for further 
research.  
 
8.4 The age related effects of volatile anaesthetics on mitochondria  
Mitochondrial and synaptosomal Ca2+-efflux rates decline with age, and the ability to 
bind Ca2+ within the mitochondria may also change (93). The consequences of increased 
cytosolic Ca2+ and altered mitochondrial Ca2+-buffering may involve mitochondrial 
depolarization or an increased propensity toward activation of the MPT (94). Reduced 
m would furthermore lower the driving force for Ca2+ entry and clearance of cytosolic 
Ca2+ load.  
The depolarizing effect of isoflurane on neural mitochondria is more pronounced in the 
adolescent and adult than in neonatal synaptosomes (paper III). Previously it has been 
shown that isoflurane enhances suppresion of excitatory synaptic transmission in the aged 
rat hippocampus (95), and that increased sensitivity of mature synapses to anaesthetic 
action is not due to altered nerve fibre conduction (96). Taken together these findings 
suggest the involvement of synaptic sites in the age dependent potentiation of anaesthetic 
action. A lower overall energy requirement in neonates and a different distribution of 
glutamate receptors might be involved in the observed difference in mitochondrial 
sensitivity (97, 98) . 
 In the present study the isoflurane induced depolarization was enhanced in all age groups 
when complex V was blocked. The neonatal rats thus preserved the m better during 
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isoflurane exposure than adolescent and adult rats, indicating a more pronounced reversal 
of ATP synthase at complex V in neonates. The increased mitochondrial sensitivity with 
age seems to be related to the reversed function of the ATP synthase of the electron 
transport chain. 
 The effect of isoflurane on [Ca2+]i was not influenced by age. When extracellular Ca2+ 
was removed, isoflurane still decreased the m, and the effect was more pronounced in 
the adolescent and adult than in neonatal synaptosomes. The age dependent isoflurane 
sensitivity thus seems to be linked to a mitochondrial site rather than changes in [Ca2+]i.  
 
8.5 Volatile anaesthetics and clinical implications 
In the present thesis, the neuroprotective possibilities of VA during OGD have not been 
studied. However, since VA, such as isoflurane and sevoflurane, are frequently used in 
patients at risk for ischemic tissue damage, a neuroprotective potential is of considerable 
clinical interest, and will be briefly discussed.  
VA possess neuroprotective properties in both in vivo and in vitro animal models of 
ischemia (99, 100). One possible mechanism would be their ability to reduce neuronal 
excitability through enhanced inhibitory and depressed excitatory synaptic transmission 
(101-103). It has been reported that small bursts of ROS production may initiate 
preconditioning in the myocardium (104, 105), and that isoflurane induced such a ROS 
production by inhibiting the respiratory chain in myocardial mitochondria (106). VA may 
also precondition brain against ischemia by activating mito KATP (107, 108). In the 
present study, we demonstrate that isoflurane and sevoflurane inhibits the respiratory 
chain in neural mitochondria. Whether this effect could stimulate a burst of ROS 
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production, that in turn may act neuroprotective, is an interesting topic for further 
research.  
The electrochemical potential across the mitochondrial inner membrane is important for 
cellular Ca2+-regulation (80). During ischemia, when the cytosolic Ca2+-concentration 
rapidly increases, mitochondria are vulnerable to a Ca2+-overload known to trigger the 
lethal MPT (78, 109). The slow dissipation of the m produced by isoflurane and 
sevoflurane may attenuate ischemic mitochondrial Ca2+-overload in the presynaptic 
terminal by lowering the driving force for Ca2+-uptake (37, 110), and thus prevent the 
activation of necrotic and apoptotic pathways or attenuate the oxidative stress (111). In 
addition, a decrease in the m is known to reverse the ATP synthase leading to 
depletion of cytoplasmatic ATP, and is generally associated with neurotoxicity (37). 
Whether a slow mitochondrial depolarization may be a neuroprotective mechanism must 
therefore be interpreted with caution.  
 Recent studies have demonstrated that anaesthetic agents can protect the brain in 
experimental models both during ischemia and by preconditioning before an ischemic 
injury (112-114). Anaesthetic agents influence the pathophysiology of cerebral ischemia 
at multiple levels. VA reduce ischemia induced glutamate release, inhibit postsynaptic 
glutamate receptors (115), and enhance GABA mediated hyperpolarization (116). In 
addition, they increase the level of antiapoptotic proteins such as Bcl-2 (117) that reduce 
mitochondrial permeability transition, cytochrome C release and subsequent activation of 
apoptosis cascades. 
Preconditioning has been demonstrated for isoflurane (108) and sevoflurane by activation 
of sarcolemmal and mitochondrial potassium–ATP channels, activation of adenosine, and 
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activation of signal transduction pathways such as ERK ½, Akt, PKC and P38 (118, 119). 
Furthermore, a recent investigation by Engelhard et al. observed increased neurogenesis 
by sevoflurane 4 weeks after cerebral ischemia (120), and suggesting the possibility that 
anaesthetics may effect post ischemic CNS regeneration. 
Despite the vast number of studies exploring the cerebral effects of anaesthetics, it is yet 
not known whether some of the VA are neuroprotective in clinical settings (47, 114, 121). 
To obtain this kind of knowledge, it might be important to elucidate the molecular 
mechanisms of action of the different VA in vitro. This information could be utilized to 
design further in vitro and in vivo studies testing the neuroprotective potential of different 
anaesthetic agents during OGD and excitotoxic stimuli. VA induced neuroprotection is a 
crucial topic for future research, as revealing clinical relevant neuroprotective 
mechanisms could make an immense improvement in the outcome from brain injury and 
cerebrovascular diseases. 
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9. MAIN CONCLUSIONS 
 
The main conclusions in the present thesis are: 
1. Sevoflurane slowly depolarizes the mitochondrial membrane in isolated CNS 
presynaptic terminals, and this effect is not dependent on Ca2+-influx to the cytosol. 
Opening of mitoKATP is only partly responsible for this depolarizing effect of 
sevoflurane. 
 
2. Isoflurane and sevoflurane depolarize presynaptic mitochondria through inhibition 
of the electron transport chain. Isoflurane seems to inhibit mitochondrial function more 
pronounced than sevoflurane. Both agents inhibit the respiratory chain sufficiently to 
cause ATP synthase reversal. 
 
3. Isoflurane depolarizes the m of neural mitochondria in an age dependent 
manner by inhibition of the respiratory chain. The effect is more pronounced in the 
adolescent and adult than in neonatal rats.  
 
4. Sevoflurane and propofol at equipotent doses depolarize the mitochondria in rat 
and human nerve terminals to the same extent. The depolarizing effect of propofol on the 
m was more rapid in onset than that of sevoflurane. Whereas sevoflurane inhibits the 
respiratory chain sufficiently to cause ATP synthase reversal, the depolarizing effect of 
propofol seems to be related to inhibition of the respiratory chain from complex I-V. 
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